Andrew Huberman and neuroscientist Scott Kanoski cover how food choices affect memory and cravings, with early chapters on natural GLP-1 and the drugs.
Recap by typeshit. Post by Andrew D. Huberman, Ph.D. on X.
A retrospective study in Cureus looks back at how well once-weekly semaglutide worked, and how safe it was, for teenagers with obesity.
Presented at Sleep Europe 2026, both trials found retatrutide lowered the apnea-hypopnea index more than placebo, including in people with type 2 diabetes.
Endpoints News
Endpoints reports Eli Lilly is building a case for its triple agonist beyond obesity, where a launch is expected next year, with sleep apnea next in line.
Observational data link GLP-1 drugs to fewer cases of some cancers, but trials have yet to show they prevent cancer or help survival after a diagnosis.
She expected a higher Zepbound dose to simply mean better results and found there was more to learn. Her personal list of lessons is on TikTok.
A short clip on handling a vial after drawing from it, with no creator, drug or other context given. Thin on detail, so check the source before relying on any advice.
Loading…